Treatment of cardiovascular disease with very low dose Rivaroxaban in Advanced Chronic Kidney disease (The TRACK Trial)
GA ID:
Agency:
National Health and Medical Research Council (NHMRC)
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019
to
31-Dec-2023
Value (AUD):
$5,522,417.59
Recipient Name:
University of New South Wales
Last Updated:
21-Dec-2018 9:51 am (ACT Local Time)